carbamazepine has been researched along with Atherogenesis in 8 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The participants included 53 epilepsy patients who received either valproic acid (VPA, n=26) or oxcarbazepine (OXC, n=27)." | 7.79 | Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. ( Arga, M; Arhan, E; Biberoglu, G; Cansu, A; Emeksiz, HC; Gulbahar, O; Hasanoglu, A; Serdaroglu, A, 2013) |
| "The participants included 53 epilepsy patients who received either valproic acid (VPA, n=26) or oxcarbazepine (OXC, n=27)." | 3.79 | Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs. ( Arga, M; Arhan, E; Biberoglu, G; Cansu, A; Emeksiz, HC; Gulbahar, O; Hasanoglu, A; Serdaroglu, A, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, DW | 1 |
| Lee, SY | 1 |
| Shon, YM | 1 |
| Kim, JH | 1 |
| Sankhyan, N | 1 |
| Gulati, S | 1 |
| Hari, S | 1 |
| Kabra, M | 1 |
| Ramakrishnan, L | 1 |
| Kalra, V | 1 |
| Castro-Gago, M | 1 |
| Eirís-Puñal, J | 1 |
| Chuang, YC | 1 |
| Chuang, HY | 1 |
| Lin, TK | 1 |
| Chang, CC | 1 |
| Lu, CH | 1 |
| Chang, WN | 1 |
| Chen, SD | 1 |
| Tan, TY | 1 |
| Huang, CR | 1 |
| Chan, SH | 1 |
| Yildiz, M | 1 |
| Oz, O | 1 |
| Akgün, H | 1 |
| Yücel, M | 1 |
| Gökçil, Z | 1 |
| Odabaşi, Z | 1 |
| Emeksiz, HC | 1 |
| Serdaroglu, A | 1 |
| Biberoglu, G | 1 |
| Gulbahar, O | 1 |
| Arhan, E | 1 |
| Cansu, A | 1 |
| Arga, M | 1 |
| Hasanoglu, A | 1 |
| Tekgul, H | 1 |
| Demir, N | 1 |
| Gokben, S | 1 |
8 other studies available for carbamazepine and Atherogenesis
| Article | Year |
|---|---|
Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
Topics: Adult; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins B; Atherosclerosis; Biomarkers; Carbamaz | 2013 |
Noninvasive screening for preclinical atherosclerosis in children on phenytoin or carbamazepine monotherapy: a cross sectional study.
Topics: Anticonvulsants; Atherosclerosis; Carbamazepine; Carotid Arteries; Carotid Intima-Media Thickness; C | 2013 |
Correspondence on "Lipid profile, apolipoproteins A and B in children with epilepsy''.
Topics: Adolescent; Anticonvulsants; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Atherosclerosis | 2009 |
Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Atherosclerosis; Blood Glucose; Carbamazepine; Carotid Art | 2012 |
Thyroid hormones may contribute to vascular risk factors and atherosclerosis.
Topics: Anticonvulsants; Atherosclerosis; Carbamazepine; Carotid Artery, Common; Epilepsy; Female; Humans; M | 2012 |
Asymmetric dimethylarginine may contribute to vascular risk factors in patients receiving antiepileptic drug treatment.
Topics: Anticonvulsants; Atherosclerosis; Carbamazepine; Carotid Artery, Common; Epilepsy; Female; Humans; M | 2012 |
Assessment of atherosclerosis risk due to the homocysteine-asymmetric dimethylarginine-nitric oxide cascade in children taking antiepileptic drugs.
Topics: Adolescent; Anticonvulsants; Arginine; Atherosclerosis; Biomarkers; Carbamazepine; Child; Epilepsy; | 2013 |
Serum lipid profile in children receiving anti-epileptic drug monotherapy: is it atherogenic?
Topics: Adolescent; Anticonvulsants; Apolipoproteins; Atherosclerosis; Carbamazepine; Child; Cholesterol, HD | 2006 |